George Coukos | |
|---|---|
 | |
| Born | December 23, 1961 |
| Alma mater | University of Modena, Italy
University of Patras, Greece University of Pennsylvania, USA |
| Scientific career | |
| Fields | Cancer immunotherapy |
George Coukos (born December 23, 1961) is a physician-scientist in tumor immunology, professor and director of the Ludwig Cancer Research Lausanne Branch and director of the Department of oncology UNIL-CHUV of the University of Lausanne and the Lausanne University Hospital in Lausanne, Switzerland.[1] He is known for his work on the mechanisms by which tumors suppress anti-cancer immune responses, and the role of the tumor vasculature in that suppression.[2] In addition to his work in ovarian cancer, the combinatorial immune therapies proposed by Professor Coukos have been successfully tested and approved for lung, liver and kidney cancers.[3]
- ^ "George Coukos: a temple from translational research". Cancer World Archive. 2015-01-01. Retrieved 2021-12-17.
- ^ "Ludwig Cancer Research". Retrieved 2021-12-17.
- ^ "The ESMO 2021 Award for Translational Research recognizes the work of the Department of Oncology UNIL CHUV and the Ludwig Institute for Cancer Research Lausanne by rewarding its director, Prof. George Coukos". CHUV (in Swiss French). Retrieved 2021-12-17.